Myocarditis as a trigger for the expression of biventricular arrhythmogenic cardiomyopathy in desmosomal gene mutation.
ICC criteria
biventricular arrhythmogenic-cardiomyopathy
gene expression
myocarditis
plakophilin-2 gene mutation
sudden cardiac death
Journal
Echocardiography (Mount Kisco, N.Y.)
ISSN: 1540-8175
Titre abrégé: Echocardiography
Pays: United States
ID NLM: 8511187
Informations de publication
Date de publication:
10 2023
10 2023
Historique:
revised:
16
07
2023
received:
24
06
2023
accepted:
20
07
2023
medline:
11
10
2023
pubmed:
11
8
2023
entrez:
10
8
2023
Statut:
ppublish
Résumé
Arrhythmogenic-cardiomyopathy (ACM) is an inherited heart disease with right, left, or biventricular (BVACM) involvement based on EKG, imaging, family history, and genetic testing. We present a 64-year-old woman with prior myocarditis and diagnosis of BVACM 29 years later. We propose myocarditis as a promoter of gene expression of plakophilin-2 mutation.
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1122-1126Informations de copyright
© 2023 The Authors. Echocardiography published by Wiley Periodicals LLC.
Références
Corrado D, Perazzolo Marra M, Zorzi A, et al. Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria. Int J Cardiol. 2020;319:106-114.
Corrado D, Zorzi A, Cipriani A, et al. Evolving diagnostic criteria for arrhythmogenic cardiomyopathy. J Am Heart Assoc. 2021;10:e021987. doi:10.1161/JAHA.121.021987
Towbin JA, McKenna WJ, Abrams DJ, et al. HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16:e373-e407.
te Riele AS, Tandri H, Bluemke DA. Arrhythmogenic right ventricular cardiomyopathy: cardiovascular magnetic resonance update. J Cardiovasc Magn Reson. 2014;16:50. doi:10.1186/s12968-014-0050-8
Dalal D, Molin LH, Piccini J, et al. Clinical features of arrhythmogenic right ventricular cardiomyopathy associated with mutations in plakophilin-2. Circulation. 2006;113:1641-1649.
Bosman LP, Te Riele ASJM. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification. Heart. 2022;108:90-97.
Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43:3997-4126.
Saguner AM, Brunckhorst C, Duru F. Arrhythmogenic ventricular cardiomyopathy:a paradigm shift from right to biventricular disease. World J Cardiol. 2014;26:154-174.
Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation. 2010;121:1533-1541.
Bosman LP, Sammani A, James CA, et al. Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: a systematic review and metanalysis. Heart Rhythm. 2018;15:1097-1107.
Cadrin-Tourigny J, Bosman LS, Wang W, et al. Sudden cardiac death prediction in arrhythmogenic right ventricular cardiomyopathy: a multinational collaboration. Circ Arrhythm Electrophysiol. 2021;14(1):e008509.
Seferovic PM, Polovina M, Bauersachs J, et al. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019;21:553-576.
Bariani R, Rigato I, Cipriani A, et al. Myocarditis-like episodes in patients with arrhythmogenic cardiomyopathy: a systematic review on the so-called hot-phase of the disease. Biomolecules. 2022;19:1324. doi:10.3390/biom12091324
Pilichou K, Remme CA, Basso C, et al. Myocyte necrosis underlies progressive myocardial dystrophy in mouse Dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med. 2009;206:1787-1802.
Chatterjee D, Fatah M, Akdis D, et al. An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis. Eur Heart J. 2018;39:3932-3944.